{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:37:55Z","timestamp":1790951875367,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02679-1","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:12:19Z","timestamp":1679865139000},"page":"2811-2824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients"],"prefix":"10.1007","volume":"43","author":[{"given":"Ainura","family":"Mussakulova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Balmukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alua","family":"Aubakirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnur","family":"Zhunusova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altynay","family":"Balmukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilya","family":"Issakhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Saliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shynar","family":"Tanabayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildar","family":"Fakhradiyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"2679_CR1","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125","volume":"2015","author":"J Barrio-Barrio","year":"2015","unstructured":"Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Vel\u00e1zquez-Villoria \u00c1, Galofr\u00e9 JC (2015) Graves\u2019 ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol 2015:249125","journal-title":"J Ophthalmol"},{"issue":"2","key":"2679_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM et al (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol 16(2):104\u2013116","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2679_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/105072502753600160","volume":"12","author":"Y Hiromatsu","year":"2002","unstructured":"Hiromatsu Y, Kaku H, Miyake I, Murayama S, Soejima E (2002) Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12(3):217\u2013221","journal-title":"Thyroid"},{"issue":"1","key":"2679_CR4","doi-asserted-by":"publisher","first-page":"101388","DOI":"10.1016\/j.beem.2020.101388","volume":"34","author":"A Antonelli","year":"2020","unstructured":"Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I et al (2020) Graves\u2019 disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab 34(1):101388","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2679_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","volume":"5","author":"WM Wiersinga","year":"2017","unstructured":"Wiersinga WM (2017) Advances in treatment of active, moderate-to-severe Graves\u2019 ophthalmopathy. Lancet Diabetes Endocrinol 5(2):134\u2013142","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2679_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol 52(3):267\u2013271","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2679_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","volume":"33","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fang S, Li D, Zhou H, Li B, Fan X (2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye 33(2):176\u2013182","journal-title":"Eye"},{"issue":"9","key":"2679_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1089\/thy.2007.0405","volume":"18","author":"AG Gianoukakis","year":"2008","unstructured":"Gianoukakis AG, Khadavi N, Smith TJ (2008) Cytokines, Graves\u2019 disease, and thyroid-associated ophthalmopathy. Thyroid Off J Am Thyroid Assoc 18(9):953\u2013958","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2679_CR9","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D \u0141acheta","year":"2019","unstructured":"\u0141acheta D, Mi\u015bkiewicz P, G\u0142uszko A, Nowicka G, Struga M, Kantor I et al (2019) Immunological aspects of Graves\u2019 ophthalmopathy. Biomed Res Int 2019:7453260","journal-title":"Biomed Res Int"},{"issue":"8","key":"2679_CR10","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1167\/iovs.13-13704","volume":"55","author":"D Huang","year":"2014","unstructured":"Huang D, Luo Q, Yang H, Mao Y (2014) Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55(8):4935\u20134943","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2679_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","volume":"250","author":"SE Kim","year":"2012","unstructured":"Kim SE, Yoon JS, Kim KH, Lee SY (2012) Increased serum interleukin-17 in Graves\u2019 ophthalmopathy. Graefe\u2019s Arch Clin Exp Ophthalmol. 250(10):1521\u20131526","journal-title":"Graefe's Arch Clin Exp Ophthalmol."},{"issue":"5","key":"2679_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1507\/endocrj.EJ12-0264","volume":"60","author":"L Zheng","year":"2013","unstructured":"Zheng L, Ye P, Liu C (2013) The role of the IL-23\/IL-17 axis in the pathogenesis of Graves\u2019 disease. Endocr J 60(5):591\u2013597","journal-title":"Endocr J"},{"issue":"8","key":"2679_CR13","doi-asserted-by":"publisher","first-page":"e3125","DOI":"10.1210\/clinem\/dgab154","volume":"106","author":"L Shi","year":"2021","unstructured":"Shi L, Ye H, Huang J, Li Y, Wang X, Xu Z et al (2021) IL-38 Exerts anti-inflammatory and antifibrotic effects in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 106(8):e3125\u2013e3142","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2679_CR14","doi-asserted-by":"publisher","first-page":"20597","DOI":"10.1074\/jbc.M010095200","volume":"276","author":"H Lin","year":"2001","unstructured":"Lin H, Ho AS, Haley-Vicente D, Zhang J, Bernal-Fussell J, Pace AM et al (2001) Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 276(23):20597\u201320602","journal-title":"J Biol Chem"},{"issue":"11","key":"2679_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/107999001753289505","volume":"21","author":"JT Bensen","year":"2001","unstructured":"Bensen JT, Dawson PA, Mychaleckyj JC, Bowden DW (2001) Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J Interferon Cytokine Res 21(11):899\u2013904","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"2679_CR16","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.1121534109","volume":"109","author":"FL van de Veerdonk","year":"2012","unstructured":"van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG et al (2012) IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A 109(8):3001\u20133005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2679_CR17","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.intimp.2020.107300","volume":"91","author":"Y Pan","year":"2021","unstructured":"Pan Y, Wang M, Chen X, Chen Y, Ai S, Su W et al (2021) Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy. Int Immunopharmacol 91:107300","journal-title":"Int Immunopharmacol"},{"key":"2679_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","volume":"65","author":"WD Xu","year":"2018","unstructured":"Xu WD, Su LC, He CS, Huang AF (2018) Plasma interleukin-38 in patients with rheumatoid arthritis. Int Immunopharmacol 65:1\u20137","journal-title":"Int Immunopharmacol"},{"key":"2679_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cytogfr.2018.01.001","volume":"39","author":"T Garraud","year":"2018","unstructured":"Garraud T, Harel M, Boutet MA, Le Goff B, Blanchard F (2018) The enigmatic role of IL-38 in inflammatory diseases. Cytokine Growth Factor Rev 39:26\u201335","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"2679_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","volume":"9","author":"L Mercurio","year":"2018","unstructured":"Mercurio L, Morelli M, Scarponi C, Eisenmesser EZ, Doti N, Pagnanelli G et al (2018) IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis 9(11):1104","journal-title":"Cell Death Dis"},{"issue":"1","key":"2679_CR21","doi-asserted-by":"publisher","first-page":"e24101","DOI":"10.1002\/jcla.24101","volume":"36","author":"J Xu","year":"2022","unstructured":"Xu J, Huang G, Weng L, Gong L, Mao Y, Li Y et al (2022) Low serum interleukin-38 levels in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. J Clin Lab Anal 36(1):e24101","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"2679_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C et al (2008) Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273\u2013285","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2679_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1055\/s-0035-1554721","volume":"47","author":"M Salvi","year":"2015","unstructured":"Salvi M, Campi I (2015) Medical treatment of Graves\u2019 orbitopathy. Horm Metab Res 47(10):779\u2013788","journal-title":"Horm Metab Res"},{"issue":"18","key":"2679_CR24","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA et al (2017) Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376(18):1748\u20131761","journal-title":"N Engl J Med"},{"issue":"9","key":"2679_CR25","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, Neuh\u00e4user M, Mann K, Lederbogen S et al (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91(9):3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2679_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/IOP.0000000000002027","volume":"38","author":"LD Smith","year":"2022","unstructured":"Smith LD, Moscato EE, Seiff SR (2022) Tocilizumab for the management of thyroid-associated orbitopathy. Ophthalmic Plast Reconstr Surg 38(2):188\u2013192","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"2679_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/IOP.0b013e3181e9a063","volume":"27","author":"LR Dagi","year":"2011","unstructured":"Dagi LR, Zoumalan CI, Konrad H, Trokel SL, Kazim M (2011) Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Ophthalmic Plast Reconstr Surg 27(2):102\u2013110","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"2679_CR28","doi-asserted-by":"publisher","first-page":"e0148167","DOI":"10.1371\/journal.pone.0148167","volume":"11","author":"JY Lee","year":"2016","unstructured":"Lee JY, Bae K, Park KA, Lyu IJ, Oh SY (2016) Correlation between extraocular muscle size measured by computed tomography and the vertical angle of deviation in thyroid eye disease. PLoS ONE 11(1):e0148167","journal-title":"PLoS ONE"},{"key":"2679_CR29","volume-title":"Optic nerve decompression","author":"OO Adesina","year":"2022","unstructured":"Adesina OO, Patel BC (2022) Optic nerve decompression. StatPearls Publishing, StatPearls Treasure Island (FL)"},{"issue":"4s","key":"2679_CR30","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.ophtha.2020.01.031","volume":"127","author":"CA Gorman","year":"2020","unstructured":"Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL et al (2020) A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophthalmopathy. Ophthalmology 127(4s):S160\u2013S171","journal-title":"Ophthalmology"},{"issue":"6","key":"2679_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41433-018-0022-6","volume":"32","author":"HH Park","year":"2018","unstructured":"Park HH, Chun YS, Moon NJ, Kim JT, Park SJ, Lee JK (2018) Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy. Eye 32(6):1036\u20131041","journal-title":"Eye"},{"key":"2679_CR32","doi-asserted-by":"publisher","first-page":"5513008","DOI":"10.1155\/2021\/5513008","volume":"2021","author":"Y Cevik","year":"2021","unstructured":"Cevik Y, Taylan Sekeroglu H, Ozgen B, Erkan Turan K, Sanac AS (2021) Clinical and radiological findings in patients with newly diagnosed Graves\u2019 ophthalmopathy. Int J Endocrinol 2021:5513008","journal-title":"Int J Endocrinol"},{"issue":"9","key":"2679_CR33","doi-asserted-by":"publisher","first-page":"e0203408","DOI":"10.1371\/journal.pone.0203408","volume":"13","author":"J-W Kwon","year":"2018","unstructured":"Kwon J-W, Jee D (2018) Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment. PLoS ONE 13(9):e0203408","journal-title":"PLoS ONE"},{"key":"2679_CR34","doi-asserted-by":"publisher","first-page":"8546423","DOI":"10.1155\/2018\/8546423","volume":"2018","author":"S Feng","year":"2018","unstructured":"Feng S, Yu H, Yu Y, Geng Y, Li D, Yang C et al (2018) Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy. J Diabetes Res 2018:8546423","journal-title":"J Diabetes Res"},{"issue":"6","key":"2679_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ando.2018.08.005","volume":"79","author":"D Drui","year":"2018","unstructured":"Drui D, Du Pasquier FL, Vignal Clermont C, Daumerie C (2018) Graves\u2019 orbitopathy: diagnosis and treatment. Ann Endocrinol 79(6):656\u2013664","journal-title":"Ann Endocrinol"},{"issue":"1","key":"2679_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12020-012-9840-7","volume":"44","author":"K Cai","year":"2013","unstructured":"Cai K, Wei R (2013) Interleukin-7 expression in tears and orbital tissues of patients with Graves\u2019 ophthalmopathy. Endocrine 44(1):140\u2013144","journal-title":"Endocrine"},{"key":"2679_CR37","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML (2020) Epidemiology, natural history, risk factors, and prevention of graves\u2019 orbitopathy. Front Endocrinol 11:615993","journal-title":"Front Endocrinol"},{"issue":"1","key":"2679_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C et al (2016) The 2016 European thyroid association\/European group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy. Eur Thyroid J 5(1):9\u201326","journal-title":"Eur Thyroid J"},{"issue":"10","key":"2679_CR39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.20452\/pamw.3592","volume":"126","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Piantanida E (2016) Cigarette smoking: number one enemy for Graves ophthalmopathy. Pol Arch Med Wewn 126(10):725\u2013726","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"2679_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","volume":"26","author":"L Bartalena","year":"2012","unstructured":"Bartalena L (2012) Prevention of Graves\u2019 ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26(3):371\u2013379","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2679_CR41","first-page":"368","volume":"40","author":"JF He","year":"2004","unstructured":"He JF, Wu ZY, Yang HS, Yan JH, Mao YX, Chen ZC et al (2004) Clinical analysis of 339 cases of thyroid-associated ophthalmopathy. Chin J Ophthalmol 40(6):368\u2013372","journal-title":"Chin J Ophthalmol"},{"issue":"2","key":"2679_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.15605\/jafes.032.02.09","volume":"32","author":"AM Lat","year":"2017","unstructured":"Lat AM, Jauculan MC, Sanchez CA, Jimeno C, Sison-Pe\u00f1a CM, Pe-Yan MR et al (2017) Risk factors associated with the activity and severity of Graves\u2019 ophthalmopathy among patients at the university of the Philippines manila-Philippine general hospital. J ASEAN Fed Endocr Soc 32(2):151\u2013157","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"4","key":"2679_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","volume":"45","author":"J Pfeilschifter","year":"1996","unstructured":"Pfeilschifter J, Ziegler R (1996) Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol 45(4):477\u2013481","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2679_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","volume":"269","author":"MF Prummel","year":"1993","unstructured":"Prummel MF, Wiersinga WM (1993) Smoking and risk of Graves\u2019 disease. JAMA 269(4):479\u2013482","journal-title":"JAMA"},{"issue":"12","key":"2679_CR45","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/thy.2008.0044","volume":"18","author":"SL Lim","year":"2008","unstructured":"Lim SL, Lim AK, Mumtaz M, Hussein E, Wan Bebakar WM, Khir AS (2008) Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves\u2019 disease. Thyroid Off J Am Thyroid Assoc 18(12):1297\u20131301","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2679_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2017.10.005","volume":"128","author":"JP Gomes","year":"2018","unstructured":"Gomes JP, Watad A, Shoenfeld Y (2018) Nicotine and autoimmunity: the lotus\u2019 flower in tobacco. Pharmacol Res 128:101\u2013109","journal-title":"Pharmacol Res"},{"issue":"10","key":"2679_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/BF03350047","volume":"12","author":"L Bartalena","year":"1989","unstructured":"Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F et al (1989) More on smoking habits and Graves\u2019 ophthalmopathy. J Endocrinol Invest 12(10):733\u2013737","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2679_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/jc.2006-1824","volume":"92","author":"TJ Cawood","year":"2007","unstructured":"Cawood TJ, Moriarty P, O\u2019Farrelly C, O\u2019Shea D (2007) Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 92(1):59\u201364","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2679_CR49","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1507\/endocrj.EJ14-0246","volume":"61","author":"H Wei","year":"2014","unstructured":"Wei H, Guan M, Qin Y, Xie C, Fu X, Gao F et al (2014) Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves\u2019 ophthalmopathy. Endocr J 61(11):1087\u20131092","journal-title":"Endocr J"},{"issue":"3","key":"2679_CR50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1134\/S0026893316030134","volume":"50","author":"XL Yuan","year":"2016","unstructured":"Yuan XL, Li Y, Pan XH, Zhou M, Gao QY, Li MC (2016) Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells. Mol Biol (Mosk) 50(3):466\u2013473","journal-title":"Mol Biol (Mosk)"},{"key":"2679_CR51","doi-asserted-by":"publisher","first-page":"609593","DOI":"10.1155\/2015\/609593","volume":"2015","author":"J Shen","year":"2015","unstructured":"Shen J, Li Z, Li W, Ge Y, Xie M, Lv M et al (2015) Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers 2015:609593","journal-title":"Dis Markers"},{"issue":"4","key":"2679_CR52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.3103","volume":"16","author":"CA Nold-Petry","year":"2015","unstructured":"Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP et al (2015) IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 16(4):354\u2013365","journal-title":"Nat Immunol"}],"updated-by":[{"DOI":"10.1007\/s10792-024-03123-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000}}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02679-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:33:31Z","timestamp":1729128811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02679-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10792-024-03123-8","URL":"https:\/\/doi.org\/10.1007\/s10792-024-03123-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Local Ethics Committee of S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan (protocol of Local Ethics Committee No 3(94), dated 25.03.2020).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}